RP

Ramaji Pendem

Active Director Director DIN 06717297
DIN 06717297 First appointment Nov 2013 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Nov 2013
Shareholding value Locked Premium profile

About Ramaji Pendem

Ramaji Pendem has 12 years in corporate governance. Holds Director role. Currently with 1 company, including Rajahmundry Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06717297
Primary Designation Director
First Appointment 11 Nov 2013
Oldest Company Age 12 yrs

Current companies

Company Designation Appointment Founded Status
Director 11 Nov 2013 2013 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rajahmundry Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ramaji Pendem

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramaji Pendem

Ramaji Pendem has 12 years in corporate governance. Holds Director role. Currently with 1 company, including Rajahmundry Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Ramaji Pendem is associated with 1 company as Director.

Ramaji Pendem has expertise in General Business.

Ramaji Pendem has 12 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available